Cancer-News

Preview

Margaret von Mehren, MD on QINLOCK: Should These Studies Continue? @FoxChaseCancer
Margaret von Mehren, MD on QINLOCK: Should These Studies Continue? @FoxChaseCancer
Margaret von Mehren, MD on QINLOCK for the Treatment  of Fourth-Line Gastrointestinal Stromal Tumor @FoxChaseCancer
Margaret von Mehren, MD on QINLOCK for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor @FoxChaseCancer
Daneng Li, MD on GAIN: What are the Differences Between the Studies? @DanengLi #ASCO @cityofhope #ASCO2020
Daneng Li, MD on GAIN: What are the Differences Between the Studies? @DanengLi #ASCO @cityofhope #ASCO2020
Daneng Li, MD on GAIN: Chemotherapy Toxicity in Older Adults with Cancer @DanengLi #ASCO @cityofhope #ASCO2020
Daneng Li, MD on GAIN: Chemotherapy Toxicity in Older Adults with Cancer @DanengLi #ASCO @cityofhope #ASCO2020
Jeffrey Weitzel, MD on TP53-Associated Chip: Does This Effect Clinical Treatment? #ASCO2020 #ASCO @cityofhope
Jeffrey Weitzel, MD on TP53-Associated Chip: Does This Effect Clinical Treatment? #ASCO2020 #ASCO @cityofhope
Jeffrey Weitzel, MD on TP53-Associated Chip: How Can This Be Implemented Everywhere? #ASCO2020 #ASCO @cityofhope
Jeffrey Weitzel, MD on TP53-Associated Chip: How Can This Be Implemented Everywhere? #ASCO2020 #ASCO @cityofhope
2483 Views in the last 30 days

Preview

Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Importance of Paradigms for Precision Medicine @sloan_kettering
Importance of Paradigms for Precision Medicine @sloan_kettering
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
624 Views in the last 30 days
kidneycancer

Preview

Role of Radiation in Kidney Cancer
Role of Radiation in Kidney Cancer
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Modern Imaging Technology
Modern Imaging Technology
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
461 Views in the last 30 days
obr

Preview

Oral Therapies in the Treatment of Myeloid Malignancies @YaleCancer
Oral Therapies in the Treatment of Myeloid Malignancies @YaleCancer
RWE in Older Patients with Acute Myeloid Malignancies
RWE in Older Patients with Acute Myeloid Malignancies
Role of Venetoclax in Treatment of MDS @YaleCancer
Role of Venetoclax in Treatment of MDS @YaleCancer
PRIMO Study Investigating Duvelisib in PTCL
PRIMO Study Investigating Duvelisib in PTCL
Novel Approaches in Development for the Treatment of PTCL
Novel Approaches in Development for the Treatment of PTCL
Studies in PTCL
Studies in PTCL
415 Views in the last 30 days
HMP CME

Preview

COVID-19 & Hematologic Malignancies: Episode 7 - Infectious Disease Update
COVID-19 & Hematologic Malignancies: Episode 7 - Infectious Disease Update
COVID-19 & Hematologic Malignancies: Episode 6 - Myeloid Malignancies Update
COVID-19 & Hematologic Malignancies: Episode 6 - Myeloid Malignancies Update
COVID-19 & Hematologic Malignancies: Episode 5 - Patient Experience Update
COVID-19 & Hematologic Malignancies: Episode 5 - Patient Experience Update
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
COVID-19 & Hematologic Malignancies: Episode 3 - Myeloma Update
COVID-19 & Hematologic Malignancies: Episode 3 - Myeloma Update
COVID-19 & Hematologic Malignancies: Episode 2 - Lymphoma Update
COVID-19 & Hematologic Malignancies: Episode 2 - Lymphoma Update
317 Views in the last 30 days
ash

Preview

Venetoclax-Rituximab (VenR) in Relapsed Refractory (R R) CLL How This Affects Clinicians #ASH19 #ASH
Venetoclax-Rituximab (VenR) in Relapsed Refractory (R R) CLL How This Affects Clinicians #ASH19 #ASH
Servier's R&D Efforts in Oncology #ASH #ASH19
Servier's R&D Efforts in Oncology #ASH #ASH19
Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant #ASH19 @ClevelandClinic
Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant #ASH19 @ClevelandClinic
Are Racial Disparities in AML Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
Are Racial Disparities in AML Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Phase III Lumoxiti #ASH19
Phase III Lumoxiti #ASH19
295 Views in the last 30 days
cancergrace
The Global Resource for Advancing Cancer Education (GRACE) provides expert-mediated information on current and emerging cancer management options in order to empower patients, caregivers, and health professionals to become direct partners in cancer care.

Preview

Mandarin Lung Cancer Video Library - The Role of Immunotherapy for Unresectable Stage 3 NSCLC
Mandarin Lung Cancer Video Library - The Role of Immunotherapy for Unresectable Stage 3 NSCLC
Corona Virus and Covid 19 - Key Questions Part Four - Standard Care Changing Because of Pandemic?
Corona Virus and Covid 19 - Key Questions Part Four - Standard Care Changing Because of Pandemic?
Corona Virus and Covid 19 - Key Questions Part Three - What Preventive Measures are Trustworthy?
Corona Virus and Covid 19 - Key Questions Part Three - What Preventive Measures are Trustworthy?
Corona Virus and Covid 19 - Key Questions Part Two - Do Cancer Patients Have a Higher Risk?
Corona Virus and Covid 19 - Key Questions Part Two - Do Cancer Patients Have a Higher Risk?
Corona Virus and Covid 19 - Key Questions Part One - Should Cancer Patients Get Tested?
Corona Virus and Covid 19 - Key Questions Part One - Should Cancer Patients Get Tested?
Webside Manner - Remote Delivery of Medical Info and Care, Rapid Expansion of Telemedicine - Part 3
Webside Manner - Remote Delivery of Medical Info and Care, Rapid Expansion of Telemedicine - Part 3
227 Views in the last 30 days
VJHemOnc

Preview

Accelerating clinical trials in transplantation
Accelerating clinical trials in transplantation
Whole genome sequencing opens door for targeted Waldenström’s therapy
Whole genome sequencing opens door for targeted Waldenström’s therapy
Updated POLLUX results for early relapsed myeloma patients
Updated POLLUX results for early relapsed myeloma patients
Targeting BCMA with bispecific antibodies in R/R myeloma
Targeting BCMA with bispecific antibodies in R/R myeloma
Monoclonal antibodies: current and future potential
Monoclonal antibodies: current and future potential
Plasma cell leukemia and extramedullary disease in multiple myeloma
Plasma cell leukemia and extramedullary disease in multiple myeloma
196 Views in the last 30 days
Annual-Meeting

Preview

Having a Parent, Sibling, or Child with Blood Cancer Increases One’s Own Risk
Having a Parent, Sibling, or Child with Blood Cancer Increases One’s Own Risk
Roswell Park Researchers Identify Immune Biomarker of Response in Patients With Advanced Liver Cancer
Roswell Park Researchers Identify Immune Biomarker of Response in Patients With Advanced Liver Cancer
TAGRISSO® (OSIMERTINIB) SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN THE PHASE III FLAURA TRIAL FOR 1ST-LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER
TAGRISSO® (OSIMERTINIB) SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN THE PHASE III FLAURA TRIAL FOR 1ST-LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER
Add-On Chemo Boosts Survival in High-Risk Endometrial Cancer
Add-On Chemo Boosts Survival in High-Risk Endometrial Cancer
Dermatologists can limit skin, hair, nail side effects from cancer therapy
Dermatologists can limit skin, hair, nail side effects from cancer therapy
Niraparib induces responses in late-line, BRCA-negative ovarian cancer
Niraparib induces responses in late-line, BRCA-negative ovarian cancer
129 Views in the last 30 days
moasc

Preview

2020 Lung Cancer Updates Spotlight on Clinical Oncology
2020 Lung Cancer Updates Spotlight on Clinical Oncology
Heinz-Josef Lenz, MD Update on Molecular Targeted Therapies for Metastatic colorectal cancers @KeckMedUSC @MOASC_office #ColorectalCancer
Heinz-Josef Lenz, MD Update on Molecular Targeted Therapies for Metastatic colorectal cancers @KeckMedUSC @MOASC_office #ColorectalCancer
Tanya Dorff, MD Genitourinary Cancers:Evolving Practices and Controversies @MOASC_Office @cityofhope
Tanya Dorff, MD Genitourinary Cancers: Evolving Practices and Controversies @MOASC_Office @cityofhope
Zev A. Wainberg, MD Updates in Gastrointestinal Cancers @MOASC_Office @dgsomucla
Zev A. Wainberg, MD Updates in Gastrointestinal Cancers @MOASC_Office @dgsomucla
Nick McAndrew, MD MSCE Updates in Breast CancerSummary of 2019 practice changing studies @MOASC_Office @dgsomucla
Nick McAndrew, MD MSCE Updates in Breast Cancer Summary of 2019 practice changing studies @MOASC_Office @dgsomucla
Herbert Eradat, MD, MS An Update on Diffuse Large B-Cell Lymphoma Novel Therapeutic Strategies @MOASC @dgsomucla
Herbert Eradat, MD, MS An Update on Diffuse Large B-Cell Lymphoma Novel Therapeutic Strategies @MOASC @dgsomucla
119 Views in the last 30 days